Invention Grant
US09534221B2 Targeting the steroidogenic pathway for treating and/or preventing allergic diseases
有权
针对类固醇生成途径治疗和/或预防过敏性疾病
- Patent Title: Targeting the steroidogenic pathway for treating and/or preventing allergic diseases
- Patent Title (中): 针对类固醇生成途径治疗和/或预防过敏性疾病
-
Application No.: US14160747Application Date: 2014-01-22
-
Publication No.: US09534221B2Publication Date: 2017-01-03
- Inventor: Erwin W. Gelfand , Meiqin Wang , Yi Jia
- Applicant: National Jewish Health
- Applicant Address: US CO Denver
- Assignee: National Jewish Health
- Current Assignee: National Jewish Health
- Current Assignee Address: US CO Denver
- Agency: Sheridan Ross P.C.
- Main IPC: A61K31/451
- IPC: A61K31/451 ; C12N15/113 ; A61K31/444 ; A61K31/58 ; A61K31/7105
Abstract:
The present invention relates to methods and compositions for treating and/or preventing allergic diseases or conditions by inhibiting one or more components of the steroidogenic pathway.
Public/Granted literature
- US20140206749A1 Targeting the Steroidogenic Pathway For Treating and/or Preventing Allergic Diseases Public/Granted day:2014-07-24
Information query
IPC分类:
